SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell Technologies shares surged after the company reported record quarterly results, driven by strong demand for AI-optimized servers and a significant boost to its full-year financial guidance. Community members remain largely bullish on the AI infrastructure theme, though some traders express skepticism regarding the company's reliance on supplier financing and high accounts payable.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

The community is heavily focused on the token's significant growth potential, driven by its unique tokenomics, large supply, and the belief that its 13-decimal place structure acts as a "leverage" for retail investors to achieve life-changing wealth. Traders are debating its status as the "Bitcoin of memecoins," often citing its decentralized nature, community backing, and the cultural influence of the associated imageboard.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares are trending following the official leadership transition from Tim Cook to new CEO John Ternus, who signaled optimism regarding upcoming hardware launches. Traders are reacting to the executive change alongside anticipation for a major product event, while sentiment remains polarized between those betting on continued momentum and those expressing skepticism over the stock's valuation.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market participants are reacting to escalating geopolitical tensions in the Middle East following U.S. strikes on Iranian targets, which have driven a surge in oil prices and U.S. Treasury yields. While some traders express bearish sentiment due to inflation and recession concerns, others view the market's resilience and strong corporate earnings from major technology companies as opportunities for potential upside.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending lower as investors react to escalating geopolitical tensions in the Middle East, rising crude oil prices, and climbing Treasury yields. Traders are expressing significant uncertainty and apprehension, with many debating whether the market's resilience will hold or if the combination of geopolitical risk and potential Federal Reserve interest rate hikes will trigger a broader correction.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

OKLO is facing downward pressure amid concerns over sustained insider selling and a lack of near-term commercial revenue, leading to community frustration and a pivot toward bearish sentiment. While some traders continue to focus on the company's long-term potential in nuclear energy and potential data center partnerships, others are concerned about the stock nearing 52-week lows.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently the subject of intense speculation ahead of upcoming earnings as traders debate whether AI infrastructure demand and custom silicon partnerships can drive a rebound after a period of sustained downward pressure. While some investors view the recent price drop as a value opportunity, others express significant skepticism regarding the stock's performance and the company's future guidance.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trading higher amid growing anticipation for the upcoming Cybercab robotaxi unveiling, as investors track expanding service areas and increased fleet activity in Texas. While retail sentiment remains divided, many traders are debating whether the rally reflects genuine growth potential or a "sell the news" event following the recent gains.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's stock is trending following a strong quarterly earnings report that featured a revenue beat and upwardly revised full-year guidance, driven by robust demand for its weight-loss and diabetes treatments. Investors are closely watching the company's competitive standing as it scales its oral and injectable drug franchises while navigating ongoing legal efforts against unauthorized sales.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is trending amid ongoing community debate regarding the project's long-term utility and recent infrastructure developments, such as the Onyx Mesh launch. While some traders express optimism about its institutional potential and staking rewards, others remain highly skeptical, frequently citing the asset's poor historical price performance and labeling it a long-term liquidity scam.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects

ALNY, BMRN, RARE and BBIO offer rare-disease growth potential through strong products, pipeline catalysts and high unmet medical needs.

RARE Stock Gains on FDA Nod for Rare Disease Gene Therapy Genglycos

Ultragenyx stock rises as Genglycos wins FDA's accelerated approval as the first treatment targeting the underlying cause of GSDIa, boosting its rare-disease portfolio.

Ultragenyx’s Gene-Therapy Win Could Unlock A ‘Long Revenue Tailwind,’ Says Wells Fargo — This Analyst Sees 265% Upside For RARE Stock

Equity

Analysts raised their price targets on RARE stock after the FDA granted accelerated regulatory approval for its rare metabolic disease therapy.


Futures Slide As Treasury Yields Surge, Erasing Bessent Intervention, Driven By Oil Spike

Futures Slide As Treasury Yields Surge, Erasing Bessent Intervention, Driven By Oil Spike

 US futures slide and are trading at session lows,?as bond yields surge after yesterday's Treasury announcement, having now erased the entire post buyback-boost move; yields are 4-5bps higher as...

RARE Stock Jumps 6% After-Hours On First Gene Therapy Approval, New Priority Review Voucher  

The FDA granted accelerated approval to GENGLYCOS, also called DTX401, for patients aged eight and older with glycogen storage disease type Ia (GSDIa). 


RARE Stock Clocks Two Consecutive Days Of Losses Ahead Of Weekend FDA Decision On Gene Therapy 

The FDA is due to rule by August 23 on Ultragenyx’s application for DTX401, a one-time gene therapy for von Gierke disease. 


Ultragenyx's Q2 Earnings Beat Estimates, Revenues Jump Y/Y

RARE beats Q2 earnings estimates as revenues surge year over year to a record quarterly high, driven by higher product sales across its portfolio.

Ultragenyx (RARE) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Ultragenyx (RARE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Ultragenyx (RARE) Reports Q2 Loss, Tops Revenue Estimates

Ultragenyx (RARE) delivered earnings and revenue surprises of +29.13% and +18.23%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Ultragenyx Q2 Loss Narrows, Reaffirms 2026 Revenue Outlook

(RTTNews) - Ultragenyx Pharmaceutical Inc. (RARE) on Tuesday reported a narrower net loss for the second quarter, as revenues grew from a year ago. The company reaffirmed its full-year 2026 revenue guidance...

• Reported GAAP EPS of -$0.90 up 23.08% YoY
• Reported revenue of $214M up 28.53% YoY
• Ultragenyx Pharmaceutical Inc. reaffirms its 2026 full-year total revenue guidance of $730 million to $760 million, excluding potential new product launches, while remaining on track toward profitability in 2027.

Ultragenyx Pharmaceutical Inc. continues to report net losses and a declining cash balance, while maintaining significant structural dependency on third-party partners for the commercialization of its primary revenue-generating product.

Ultragenyx Pharmaceutical Inc. achieved record quarterly revenue and remains on a clear path to profitability by 2027, supported by anticipated expense reductions and a robust pipeline of upcoming clinical catalysts.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

RARE Ultragenyx Pharmaceutical Inc

Fundamentals

Latest RARE News